Technology Bundle ID: TAB-2644

Methods of Detecting and Identifying Both Known and Novel Influenza Viruses

Request More Info
Licensing Contact:
Primary Inventors: 
Suxiang (Sue) Tong (CDC)
Therapeutic Area: 
Infectious Disease
Application: 
Diagnostics
Development Status: 
  • Pre-clinical
  • In vitro data available
Institute or Center: 
CDC

This invention describes materials and methods of detecting novel influenza virus in a sample. As highlighted by the recent H1N1 pandemic strain, influenza viruses are constantly evolving and novel reassortments can quickly spread around the world.

The reagents and methods of this particular technology are capable of detecting any type of influenza virus (such as influenza A virus, influenza B virus, and influenza C virus) in a sample, including novel or previously unknown influenza viruses. Such methods and compositions are useful for diagnosing influenza virus infection in humans and animals.

Applications:
  • Method of rapid, accurate subtype-screening of influenza viruses using "pan-influenza" RT-PCR
  • Diagnostic tool for clinicians, veterinarians, public health programs, food-safety officials, researchers and forensic scientists
Advantages:
  • A full-spectrum, sensitive and specific assay for identification of influenza viruses, known and novel
  • Easily adaptable for commercial production

Patents

PCT Application PCT/US2013/029600
Filed on 2013-03-07
US Application 61/642,098
Filed on 2012-05-03
US Pat 9,803,251

Issued 2017-10-31

Publications

Fouchier RA, et al.
PMID 11060074
Fouchier RA, et al.
PMID 15709000
Tong S, et al.
PMID 18579717

Updated

Sep 18, 2013

Data Source: 
tts